Update on the use of immunoglobulin in human disease: a review of evidence, J Allergy Clin Immunol, vol.139, issue.3S, pp.1-46, 2017. ,
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders, Trends Pharmacol Sci, vol.34, pp.445-57, 2013. ,
Intravenous immunoglobulin in neurology-mode of action and clinical efficacy, Nat Rev Neurol, vol.11, pp.80-89, 2015. ,
IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties, Trends Pharmacol Sci, vol.36, issue.7, pp.419-440, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01155485
Modulation of the cellular immune system by intravenous immunoglobulin, Trends Immunol, vol.29, pp.608-623, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455606
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?, Nat Rev Immunol, vol.13, pp.176-89, 2013. ,
What is the contents of the magic draft IVIG?, Autoimmun Rev, vol.7, pp.435-444, 2008. ,
Intravenous immunoglobulin (IVIG) dampens neuronal toll-like receptor-mediated responses in ischemia, J Neuroinflammation, vol.12, p.73, 2015. ,
Immunomodulation by intravenous immunoglobulin: role of regulatory T cells, J Clin Immunol, vol.30, issue.1, pp.4-8, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455581
Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin, J Allergy Clin Immunol, vol.127, pp.823-853, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455567
Molecular and immunological biomarkers to predict IVIg response, Trends Mol Med, vol.21, pp.145-152, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01117084
Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins, J Neuroinflammation, vol.12, p.148, 2015. ,
FOXP3+ regulatory T cells in the human immune system, Nat Rev Immunol, vol.10, pp.490-500, 2010. ,
Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease, J Rheumatol, vol.39, pp.450-451, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455584
Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells, Blood, vol.122, pp.1419-1446, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455532
Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function, J Immunol, vol.179, pp.5571-5576, 2007. ,
Tregitope update: mechanism of action parallels IVIG, Autoimmun Rev, vol.12, pp.436-479, 2013. ,
Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells, J Allergy Clin Immunol, vol.133, pp.853-63, 2014. ,
Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway, Nature, vol.475, pp.110-113, 2011. ,
Protection in antibody-and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs, Proc Natl Acad Sci U S A, vol.112, pp.2385-94, 2015. ,
Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies, J Neuroimmunol, vol.231, pp.61-70, 2011. ,
Intravenous immunoglobulin for Guillain-Barre syndrome, Cochrane Database Syst Rev, vol.7, p.2063, 2012. ,
Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome, Lancet Neurol, vol.7, pp.939-50, 2008. ,
Abnormality of circulating CD4 + CD25+ regulatory T cell in patients with Guillain-Barre syndrome, J Neuroimmunol, vol.192, pp.206-220, 2007. ,
Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells, Cell Immunol, vol.271, pp.455-61, 2011. ,
Intravenous immunoglobulin as clinical immune-modulating therapy, CMAJ, vol.187, pp.257-64, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455495
Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury, Exp Neurol, vol.282, pp.49-55, 2016. ,
Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition, PLoS One, vol.9, issue.9, p.107772, 2014. ,
Intravenous immunoglobulin exerts reciprocal regulation of Th1/ Th17 cells and regulatory T cells in Guillain-Barre syndrome patients, Immunol Res, vol.60, pp.320-329, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01102873
Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients, Sci Rep, vol.4, p.5672, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01358914
Expansion of CD4 + CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis, Blood, vol.111, pp.715-737, 2008. ,
Interleukin-33 in health and disease, Nat Rev Immunol, vol.16, pp.676-89, 2016. ,
Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation, Cell Mol Immunol, vol.12, pp.650-652, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455500
Plasma prostaglandin E2 levels correlated with the prevention of intravenous immunoglobulin resistance and coronary artery lesions formation via CD40L in Kawasaki disease, PLoS One, vol.11, p.161265, 2016. ,
Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood, J Allergy Clin Immunol, vol.134, pp.170-177, 2014. ,
Associations between interleukin and interleukin receptor gene polymorphisms and risk of gout, Sci Rep, vol.5, p.13887, 2015. ,
IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline, Proc Natl Acad Sci, vol.113, pp.2705-2718, 2016. ,
Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation, Brain Behav Immun, vol.49, pp.322-358, 2015. ,
IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells, PLoS Pathog, vol.11, issue.2, p.1004607, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01190147
Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-gamma and expanding CD4 + Foxp3+ T cells in concordant heart transplantation, Lab Invest, vol.96, issue.8, pp.820-829, 2016. ,
IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous system, J Neuroinflammation, vol.13, issue.1, p.159, 2016. ,